SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001104659-19-059949
Filing Date
2019-11-05
Accepted
2019-11-05 13:19:06
Documents
5

Document Format Files

Seq Description Document Type Size
1 F-3/A tm1921700d2_f3a.htm F-3/A 284474
2 EXHIBIT 23.1 tm1921700d2_ex23-1.htm EX-23.1 4194
3 GRAPHIC tm1921700d2_ex23-1img01.jpg GRAPHIC 11534
4 GRAPHIC tm1921700d2_ex23-1img02.jpg GRAPHIC 11668
5 GRAPHIC tm1921700d2_img01.jpg GRAPHIC 68179
  Complete submission text file 0001104659-19-059949.txt   415976
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: F-3/A | Act: 33 | File No.: 333-234136 | Film No.: 191192593
SIC: 2834 Pharmaceutical Preparations